The launch of the 750mcg teriparatide injection in Australia has seen controlled availability to date. Primarily designated for patients with severe osteoporosis who have not responded to other treatments , access is carefully managed. Present supply levels are limited, and sufferers should confirm from their physician the latest information on … Read More